Why is Bandaram Pharma falling/rising?

As of 08-Jul, Bandaram Pharma Packtech Ltd is currently priced at 41.65, reflecting a decrease of 0.24, or 0.57%. The stock has underperformed its sector today by 0.27% and has experienced a trend reversal, falling after four consecutive days of gains. Despite a strong one-year return of 32.26%, the stock's recent performance has been affected by a significant drop in delivery volume, which fell by 67.54% compared to the five-day average. Additionally, while the company has a very attractive valuation with a ROCE of 6.2 and a PEG ratio of 11.9, it also faces challenges such as a high Debt to EBITDA ratio of 6.31 times and flat results in its latest quarterly earnings, which may contribute to investor caution.
In the broader market context, the stock has shown a strong performance over the past week and month, with returns of 8.83% and 9.63%, respectively, compared to a negligible 0.02% and 1.85% return for the Sensex. However, year-to-date, Bandaram Pharma has underperformed the benchmark, with a decline of 6.19% against the Sensex's gain of 7.13%. This disparity highlights the stock's volatility and potential concerns regarding its long-term fundamental strength, despite its recent market-beating performance over the past year.